Cannara Biotech Delivers Highest Revenue and Profitability Since Inception in Fiscal Q3 2025
Record Revenue: Total revenues, net of excise taxes increased to $27.3 million in Q3 2025, representing a 40% increase over the prior year period. Record Profitability: Gross profit before fair value adjustments rose to $12.1 million in Q3 2025, representing …
ABOUT CANNARA
Cannara Biotech Inc.
(TSXV: LOVE
) (OTCQB: LOVFF
) (FRA: 8CB0
), is a vertically integrated producer of affordable premium-grade cannabis and cannabis-derivative products for the …